PHGE PHGE
Company Profile ↓Company Overview
PHGE (PHGE) is a publicly traded company listed on with a market capitalization of $286.87K. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of -0.00.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -97.81% |
| 6 Months: | -96.85% |
| 3 Months: | -73.53% |
| 1 Month: | -40.20% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)27.38 · Oversold
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 98.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.76M | 7.43M | 8.54M | 7.20M | 1.30M |
| Operating Income | -1.00K | -650 | -15.79K | -3.72M | -4.07M | -4.66M | -5.97M | -6.39M | -8.83M | -8.54M | -7.30M | -9.83M | -7.79M | -7.32M | -6.55M | -6.21M | -6.07M | -7.79M | -6.79M | -9.72M | -11.33M | - | -7.76M | -7.43M | -8.54M | -7.20M | -1.30M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -7.42M | -5.71M | -7.92M | -12.92M | -18.95M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.00K | 30.00K | 5.00K | -741.00K | 192.00K |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -7.66M | -6.04M | -9.16M | -13.34M | -19.14M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00K | 2.00K | 3.00K | 1.00K | 0 |
| Net Income | -1.00K | -650 | 10.46K | -3.23M | -3.78M | -4.26M | -5.90M | -6.21M | -8.84M | -8.40M | -7.34M | -10.03M | -8.17M | -7.48M | -6.78M | -6.36M | -6.41M | -7.91M | -17.33M | 4.47M | 9.64M | - | -7.66M | -6.04M | -9.17M | -13.34M | -19.14M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | 0.30 | 0.37 | 0.27 | 0.25 | 0.23 | 0.20 | 0.12 | 1.30 | 2.78 | 0.69 | -0.31 | - | -6.27 | -3.61 | -5.51 | - | -7.38 |
| R&D Expense | - | - | - | 2.74M | 2.86M | 2.86M | 3.53M | 3.72M | 6.06M | 5.67M | 3.82M | 6.61M | 4.93M | 4.58M | 3.54M | 4.56M | 3.82M | 5.64M | 4.11M | 6.90M | 7.28M | - | 5.25M | 5.01M | 6.12M | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2018 | Jun 2019 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | 27.22M | 25.35M | 35.55M | 30.92M |
| Operating Income | -12.49M | -404.52K | -22.21M | -30.26M | - | -27.22M | -25.35M | -35.55M | -30.92M |
| EBITDA | - | - | - | - | - | -23.66M | -22.87M | -15.04M | -33.25M |
| Interest Expense | - | - | - | - | - | 2.07M | 2.40M | 873.00K | 20.00K |
| Pretax Income | - | - | - | - | - | -28.25M | -26.15M | -17.71M | -36.19M |
| Tax Provision | - | - | - | - | - | 65.00K | 23.00K | 13.00K | 7.00K |
| Net Income | -12.72M | 347.41K | -20.56M | -30.09M | - | -28.32M | -26.17M | -17.73M | -36.20M |
| Diluted EPS | - | - | - | - | - | -180.50 | -96.90 | -25.37 | -22.19 |
| R&D Expense | 9.13M | - | 13.49M | 19.42M | 22.68M | 16.24M | 16.70M | 24.66M | 21.29M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2017 | Jun 2018 | Dec 2018 | Jun 2019 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 64.97K | 45.33M | 71.62M | 92.12M | 70.36M | - | 45.53M | 25.03M | 43.23M | 5.78M |
| Current Assets | - | - | - | - | - | - | - | 36.88M | 17.63M | 20.52M | 5.58M |
| Cash & Equivalents | - | 430 | 8.60M | 696.83K | 72.26M | 36.48M | - | 31.33M | 14.91M | 16.86M | 4.36M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | 567.00K | 574.00K | 1.17M | 0 |
| Total Liabilities | - | 41.00K | - | 871.01K | - | - | - | 24.49M | 21.95M | 19.09M | 7.08M |
| Current Liabilities | - | 41.00K | 1.64M | 371.01K | 6.22M | 7.16M | - | 7.94M | 11.18M | 8.27M | 6.38M |
| Long Term Debt | - | - | - | - | - | - | 14.41M | 10.59M | 5.40M | - | - |
| Total Debt | - | - | - | - | - | - | - | 19.36M | 15.09M | 9.58M | 1.44M |
| Total Equity | 11.53M | 23.98K | 42.80M | 5.00M | 84.46M | 57.47M | - | 21.04M | 3.08M | 24.15M | -1.30M |
| Shares Outstanding | - | - | - | - | - | - | - | 157.80K | 242.00K | 956.67K | 1.59M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2018 | Jun 2019 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -11.30M | -204.58K | -17.58M | -24.45M | - | -29.09M | -21.29M | -36.98M | -26.39M |
| Investing Cash Flow | -30.04M | -70.00M | 19.74M | -10.86M | - | -2.11M | 1.95M | 715.00K | 108.00K |
| Financing Cash Flow | 43.04M | 70.90M | 61.55M | 134.00K | - | 292.00K | 2.90M | 38.37M | 13.19M |
| Capital Expenditure | -137.00K | - | -1.31M | -1.01M | - | -112.00K | -50.00K | -30.00K | -2.00K |
| Free Cash Flow | -11.44M | - | -18.89M | -25.46M | - | -29.20M | -21.34M | -37.01M | -26.39M |
| Net Change in Cash | - | - | - | - | - | -30.91M | -16.44M | 2.11M | -13.09M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2018 | Jun 2019 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - | - | - | - |
| ROE % | -29.7% | 6.9% | -24.3% | -52.4% | - | -134.6% | -849.4% | -73.4% | 2,780.3% |
| ROCE % | -28.6% | -0.6% | -25.9% | -47.9% | - | -72.4% | -183.0% | -101.7% | 5,187.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PHGE
BiomX And Water.IO Agree To Updated Zorronet Acquisition Terms
Revised agreement provides BiomX with additional flexibility to support Zorronet while further aligning BiomX and Water IO around Zorronet's long-term successNETANYA, Israel, July 28, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE…
BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe
Collaboration expands Zorronet's AI-powered detection, analysis and response capabilities into agricultural security, theft and critical transportation infrastructure protectionNETANYA, Israel, July 24, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (…
BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities
NETANYA, Israel, July 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a company focused on defense, security, and critical infrastructure technologies, today announced that its wholly owned subsidia…
BiomX: Subsidiary Zorronet Commences Installation and Operation of AI-Powered Detection Systems Under Israel Railways Agreement
NETANYA, Israel, July 06, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), announced today following its April 16, 2026 announcement that its wholly-owned subsidiary Zorronet has commenced supply and ins…
BiomX: Next-Gen Counter Drone Solutions will be Showcased by DFSL at ISC 2026
NETANYA, Israel, June 24, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”) today announced that its majority-owned subsidiary company DFSL Ltd. (“DFSL”) will showcase next-generation LADAR-based counter-d…
BiomX Provides Update on Defense Technology Portfolio and Growth Strategy
Presentation reflects BiomX’s completed strategic transition and current focus on technologies that identify, analyze, and respond to physical threatsNETANYA, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE), a com…
PHGE — Frequently Asked Questions
What is the current share price of PHGE?
As of 2026-08-05 17:25 PDT, PHGE trades at $0.18 on NASDAQ/NYSE. Its 52-week range is $0.18 to $12.35.
What is the market capitalisation of PHGE?
PHGE has a market capitalisation of $286.87K on NASDAQ/NYSE.
What is the P/E ratio of PHGE?
PHGE trades at a trailing price-to-earnings (P/E) ratio of -0.01. Its price-to-book (P/B) ratio is -0.22.
Is PHGE a good stock to buy?
This page provides a data-driven analysis of PHGE, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.